Leucine Rich Bio partners with Medsol Diagnostics UAE to advance Microbiome Health Solutions

 New Delhi: Leucine Rich Bio, South Asia’s pioneering microbiome company, has announced a strategic collaboration with Medsol Diagnostics UAE, a premier diagnostics provider in the Middle East.

This partnership aims to bring BugSpeaks, Leucine Rich Bio’s innovative gut microbiome testing technology, to the UAE, empowering individuals with personalized health insights to optimize gut health and overall wellness.

At the heart of this partnership is BugSpeaks, a cutting-edge do-it-yourself test. BugSpeaks analyzes the gut microbiome to identify microbial imbalances linked to conditions like diabetes, obesity, and digestive disorders. By leveraging Medsol Diagnostics’ extensive network and expertise, this collaboration will expand access to microbiome diagnostics across the UAE, offering actionable nutritional and supplementation recommendations to improve health outcomes.

Highlighting the significance of this collaboration, Dr. Debojyoti Dhar, Co-founder and Director of Leucine Rich Bio, expressed: “We are excited to join forces with Medsol Diagnostics UAE to bring BugSpeaks to the Middle East. Our past collaborations in Brazil, Thailand, and the Philippines have shown us the transformative power of microbiome testing in diverse populations. This partnership is a step forward in making gut health a cornerstone of preventive healthcare worldwide.”

This milestone builds on Leucine Rich Bio’s successful track record of global partnerships. In Brazil, the company teamed up with Precision Diagnósticos to introduce BugSpeaks, enhancing microbiome awareness and diagnostics in South America. Similarly, collaborations with Cognoa International Inc. in the Philippines and partners in Thailand have made BugSpeaks a trusted tool for gut health in Southeast Asia, with functional medicine doctors and patients alike praising its impact on addressing chronic conditions.

Leucine Rich Bio continues to lead the charge in microbiome innovation, with plans to further expand its footprint across Asia and beyond, solidifying its mission to revolutionize healthcare through the science of the gut.